In a 45-year-old man diagnosed with nephrotic syndrome, which findings would you expect: proteinuria exceeding 3.5 grams per day, hypoalbuminemia, hyperlipidemia, increased risk of infections, or all of the above?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Nephrotic Syndrome: Expected Findings

E) All of the above is correct—you should expect to find proteinuria >3.5 g/day, hypoalbuminemia, hyperlipidemia, AND increased risk of infections in this 45-year-old man with nephrotic syndrome. 1

Diagnostic Criteria

Nephrotic syndrome is definitively characterized by the following tetrad 1:

  • Proteinuria ≥3.5 g/day (or ≥1.0 g/m²/day in children)
  • Hypoalbuminemia (<3.0 g/dL in adults; <2.5 g/dL in children)
  • Edema (oncotic edema due to low albumin)
  • Hypercholesterolemia (commonly present)

All four options A through D represent either core diagnostic features or direct complications of nephrotic syndrome, making "all of the above" the only complete answer.

Why Each Finding is Expected

Proteinuria >3.5 g/day (Option A)

This is the hallmark defining feature of nephrotic syndrome. The threshold of 3.5 g/day distinguishes nephrotic-range proteinuria from lesser degrees of proteinuria 1. This massive protein loss results from increased glomerular basement membrane permeability to albumin.

Hypoalbuminemia (Option B)

Serum albumin <3.0 g/dL in adults is a required diagnostic criterion 1. The hypoalbuminemia carries significant prognostic implications—a meta-analysis showed that each 1.0 g/dL decrease in serum albumin increases morbidity odds by 89% and mortality by 137% 1.

Hyperlipidemia (Option C)

Hypercholesterolemia is commonly present as part of the nephrotic syndrome constellation 1. This contributes to accelerated coronary heart disease risk, which is four times greater in nephrotic patients compared to age- and sex-matched controls 1.

Increased Risk of Infections (Option D)

Patients with nephrotic syndrome have a documented increased risk of serious infections, particularly cellulitis and spontaneous bacterial peritonitis in children, but infection risk is heightened across all age groups 1. This occurs due to:

  • Urinary loss of immunoglobulins and complement factors
  • Loss of immune factors in nephrotic urine
  • Immunosuppressive therapy used for treatment 2

Additional Critical Complications

Beyond the options listed, this patient faces other serious risks that impact morbidity and mortality:

Thromboembolism: Nephrotic syndrome confers substantial thrombotic risk 1:

  • 29% prevalence of renal vein thrombosis
  • 17-28% pulmonary embolism
  • 11% deep vein thrombosis
  • Particularly high in membranous nephropathy

Progressive Renal Failure: Proteinuria >3.8 g/day carries a 35% risk of end-stage renal disease within 2 years, compared to only 4% risk with proteinuria <2.0 g/day 1.

Clinical Pitfalls

Do not mistake the absence of edema or normal cholesterol as excluding nephrotic syndrome—while these are typical features, the absolute requirements are proteinuria ≥3.5 g/day and hypoalbuminemia 1. Some patients with secondary forms (like obesity-related FSGS) may have relatively preserved albumin levels despite nephrotic-range proteinuria 3.

References

Related Questions

Which of the following is NOT a typical feature of nephrotic syndrome: proteinuria >3 g per 24 hours, hypoalbuminemia, peripheral edema, glomerular hematuria, or hyperlipidemia?
Why should nephrotic syndrome be suspected in an 89‑year‑old woman with severe hypoalbuminemia, elevated C‑reactive protein, atypical edema distribution, and right‑foot skin changes?
In a patient with nephrotic syndrome who has edema, proteinuria, and hypoalbuminemia, what additional laboratory abnormality is typically present?
How should I evaluate and manage a patient with warm bilateral pitting edema, normal estimated glomerular filtration rate, normal liver function tests, progressive normocytic anemia, and proteinuria?
What potential complication can occur in a 45-year-old man with nephrotic syndrome?
In an adult with low-output heart failure or cardiogenic shock, how should dobutamine and dopamine be used, including indications, dosing, and monitoring?
For a patient with end‑stage renal disease on chronic dialysis presenting with acute coronary syndrome, can ticagrelor be used and what is the appropriate dosing regimen?
What are the recommended guidelines for initiating and titrating oral hypoglycemic agents—including metformin, sulfonylureas, sodium‑glucose cotransporter‑2 (SGLT2) inhibitors, dipeptidyl peptidase‑4 (DPP‑4) inhibitors, and thiazolidinediones—in adults with type 2 diabetes, taking into account renal function, liver disease, and hypoglycemia risk?
Should a patient on low-dose imipramine 25 mg nightly be tapered before stopping the medication?
Can a 1‑year‑old child use Flomist (fluticasone nasal spray)?
In a 2½‑year‑old girl with recent fever, decreasing leukocytosis and C‑reactive protein, a positive nasopharyngeal adenovirus PCR, and currently stable on intravenous amoxicillin, is further hospitalization required or can she be safely discharged on oral amoxicillin if she remains well‑appearing?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.